Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Citigroup Inc.

Citigroup Inc. increased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 66.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 76,772 shares of the company's stock after purchasing an additional 30,677 shares during the quarter. Citigroup Inc. owned 0.16% of Prestige Consumer Healthcare worth $5,535,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Evergreen Capital Management LLC grew its stake in Prestige Consumer Healthcare by 5.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company's stock valued at $216,000 after acquiring an additional 160 shares in the last quarter. Miller Howard Investments Inc. NY grew its holdings in shares of Prestige Consumer Healthcare by 2.2% in the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company's stock valued at $534,000 after purchasing an additional 165 shares in the last quarter. OLD National Bancorp IN grew its stake in shares of Prestige Consumer Healthcare by 4.4% in the third quarter. OLD National Bancorp IN now owns 3,974 shares of the company's stock worth $287,000 after acquiring an additional 168 shares in the last quarter. Huntington National Bank increased its holdings in Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company's stock worth $46,000 after purchasing an additional 181 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock worth $33,000 after acquiring an additional 208 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded up $0.22 during mid-day trading on Monday, hitting $84.99. 292,955 shares of the company's stock traded hands, compared to its average volume of 251,520. Prestige Consumer Healthcare Inc. has a 1 year low of $57.95 and a 1 year high of $86.36. The company has a market cap of $4.20 billion, a PE ratio of 20.68, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. The firm's 50 day simple moving average is $75.66 and its 200 day simple moving average is $71.34.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.09. The firm had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company's quarterly revenue was down .9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.07 EPS. Sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.44 EPS for the current year.

Analyst Ratings Changes

PBH has been the subject of several research analyst reports. Jefferies Financial Group restated a "hold" rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reissued a "buy" rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, Prestige Consumer Healthcare currently has an average rating of "Moderate Buy" and an average price target of $83.67.

Insider Activity

In other news, EVP Adel Mekhail sold 9,063 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total transaction of $743,166.00. Following the transaction, the executive vice president now directly owns 18,365 shares in the company, valued at $1,505,930. This represents a 33.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider William P'pool sold 8,987 shares of the firm's stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total transaction of $735,585.95. Following the completion of the sale, the insider now directly owns 20,058 shares in the company, valued at $1,641,747.30. This represents a 30.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 38,810 shares of company stock worth $3,187,300 over the last three months. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.